Skip to main content
Health Podcast Library

Does Tafamidis Attenuate the Benefits of Vutrisiran in ATTR-CM? | JACC Baran

JACC Global · 39 min

Episode Description

Does adding a gene silencer to a TTR stabiliser provide additional benefit in transthyretin amyloid cardiomyopathy (ATTR-CM)? Host Mitsuaki Sawano, MD, and co-host Nobuhiro Ikemura, MD, welcome Yasuhiro Hamatani, MD, PhD (Brigham and Women's Hospital, Harvard Medical School) to discuss his JACC study, published simultaneously with ESC 2026, examining vutrisiran efficacy according to baseline tafamidis use in the HELIOS-B trial. Although treatment benefits were directionally consistent regardless of tafamidis use, effect estimates were numerically attenuated among patients receiving tafamidis, without significant interactions for major clinical outcomes. We explore the implications for mortality, cardiovascular events, exercise capacity, and quality of life, alongside emerging evidence from CARDIO-TTRansform and a subsequent meta-analysis. Can combination therapy deliver meaningful incremental benefit, and how should these findings shape future ATTR-CM treatment strategies?

Proudly Supported by

BetterHelpForvis MazarsAAOSCalendarPAmowPod

Patrons of Health Podcast Library

AAOS Career Podcast
Achieving Health
AAOS Now Podcast
OrthoInfo
Who the Health Cares? with Prof Michael Sparer
Aging Like a Pro
Stronger After Stroke

Supporting Shows

Thriving with Addiction with Dr. Jonathan Avery
Impulse | Meeting Healthcare Pioneers
HITea With Grace
Faces of Digital Health
Beyond The Paper Gown Podcast
Coaching Healthcare Leaders
Nurse Rosa's INsights
Beyond Clinical Walls
Hopeful Hints
Cuts and Consults
On the Pulse Podcast
Coffee Break: Breaking the Cycle of Bullying in Healthcare, One Cup at a Time
Healthcare for Humans
Speak Up For Your Health
HIT Like a Girl Pod: Empowering Women in Health IT
This Just In Radio Show

We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies